kff employer health benefits survey 2025 glp-1 coverage for obesity treatment in 13 US states' Medicaid programs A new car vs. health

An intervention experiment with PA in a high-fat-diet (HFD)-induced NAFLD mouse model had demonstrated that alterations of the gut microbiota upon PA intervention had a beneficial effect on high-density lipoprotein cholesterol-induced hepatic steatosis, which plays a key role in ameliorating NAFLD (Wang X

A Narrative Review of BPC-157 for Musculoskeletal Healing Mayfield et al

Barring new drugs simply because they treat a so-called lifestyle disease fails to maintain a standard of equal moral concern. These lessons emphasize the imperative for balanced, evidence-based approaches to U.S

"These drugs have the potential to bring about substantial weight loss, particularly in the first year," says Juan Franco, co-lead researcher from Heinrich Heine University Dsseldorf, Germany